Dr Rajvinder Karda is a Professor In Gene Therapy at the Institute for Women’s Health, UCL. She completed her PhD in Gene Transfer and Neuroscience at Imperial College London in 2016. Her research team mainly focuses on developing pre-clinical gene therapy and RNA editing treatments for childhood neurological disorders. Dr Karda has received funding as a principal investigator from MRC DPFS, LifeArc, GOSH Charity, Dravet Syndrome UK Charity, Cure DHDDS charity and Venture Capital funds. She also collaborates on pre-clinical gene therapy projects for rare childhood metabolic disorders. She is currently a board member of the British Gene and Cell Therapy Society and a member of the Scientific Advisory Committee for the Dravet Foundation Charity in Spain and Cure DHDDS Charity in the UK.
